drugset / Trial / NCT01830517

Diurnal Variation in Hypertensive Stroke Patients

NCT01830517

Phase 4 Completed 84 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was conducted to evaluate and compare the effectiveness of Amodipin® (amlodipine camsylate) with that of Cozaar® (losartan potassium) in hypertensive patients with an acute ischemic stroke by measuring their 24-hour ambulatory BP (ABP).

Timeline

Start
2007-08
Primary completion
2011-06
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Losartan Other / unclassified 50 mg